OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 6
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 6
Showing 6 citing articles:
Development of 99mTc-Labeled Complexes with a Niraparib HYNIC Derivative for PARP-Positive Tumor Imaging
Qianna Wang, Junhong Feng, Yuhao Jiang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Qianna Wang, Junhong Feng, Yuhao Jiang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA
Zhikun Liu, Shining Mao, Lumei Dai, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117936-117936
Closed Access
Zhikun Liu, Shining Mao, Lumei Dai, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117936-117936
Closed Access
PARP Inhibitors in Pancreatic Cancer with Homologous Recombination Repair Gene Mutations: A Single-Institution Experience
Ruoyu Miao, Kirsten Blue, Katelyn Sommerer, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3447-3447
Open Access
Ruoyu Miao, Kirsten Blue, Katelyn Sommerer, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3447-3447
Open Access
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship
E Haripriya, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access
E Haripriya, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access
Discovery of Pyrazolo[1,5,4-de]quinoxalin-2(3H)-one Derivatives as Highly Potent and Selective PARP1 Inhibitors
Shanyun Gao, Yingjie Hou, Yanxiao Xu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Shanyun Gao, Yingjie Hou, Yanxiao Xu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
The Potential of PARP Inhibitors as Antitumor Drugs and the Perspective of Molecular Design
Yinghan Wang, Jingtao Zhang, Xiaochen Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 68, Iss. 1, pp. 18-48
Closed Access
Yinghan Wang, Jingtao Zhang, Xiaochen Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 68, Iss. 1, pp. 18-48
Closed Access
